Improvement of bone mineral density after enzyme replacement therapy in Chinese late-onset Pompe disease patients
Abstract Objective Late-onset Pompe disease (LOPD) is a lysosomal storage disease resulted from deficiency of the enzyme acid α-glucosidase. Patients usually develop a limb-girdle pattern of myopathy and respiratory impairment, and enzyme replacement therapy (ERT) is the only specific treatment avai...
Main Authors: | Bun Sheng, Yim Pui Chu, Wa Tai Wong, Eric Kin Cheong Yau, Sammy Pak Lam Chen, Wing Hang Luk |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-017-2681-y |
Similar Items
-
Pregnancy Outcomes in Late Onset Pompe Disease
by: Ozlem Goker-Alpan, et al.
Published: (2020-09-01) -
Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
by: Barry J. Byrne, et al.
Published: (2024-10-01) -
Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease
by: Barry J. Byrne, et al.
Published: (2025-01-01) -
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
by: Nuria Gómez-Cebrián, et al.
Published: (2023-08-01) -
Clinical and Genetic Aspects of Pompe Disease: A Review of Current Knowledge
by: Agata Konopka, et al.
Published: (2024-08-01)